National Launch of the ShurFit 2C Interbody Systems Featuring Titanium Plasma Spray and Hydroxyapatite Coating

ShurFit 2C Interbody Systems: Precision Spine, Inc. has launched nationally the ShurFit ACIF 2C Anterior Cervical, TLIF 2C, and TPLIF 2C Posterior Interbody Systems, which is made from medical grade polyetheretherketone (Peek Optima, LT1) and coated with both commercially pure Titanium (Ti) and Hydroxyapatite (HA).

“The ShurFit 2C Interbody System’s distinguishing feature is its unique coating of both Titanium and Hydroxyapatite that helps increase durability and makes enhanced fixation possible while the process of biologic fusion takes place,” said Stephen D. Cook, Ph.D., Executive Director and Founder of the Fellowship of Orthopaedic Researchers, who was instrumental in the design and development of the device with Precision Spine engineers.

The ShurFit 2C coating technology combines a high-strength PEEK core with a unique, dual layer of coatings applied directly to the endplate surfaces. A biocompatible plasma-sprayed CP Titanium coating, with an outer layer of osteoconductive Hydroxyapatite, provides an optimal environment for osseointegration. The dual coating promotes rapid bone formation, which offers implant stability, less potential for implant migration, and the formation of a stable fusion mass while strategically placed tantalum markers facilitate radiographic implant positioning.

“The ShurFit ACIF 2C Systems are an important addition to our growing portfolio of devices,” said Chris DeNicola, Chief Operating Officer of Precision Spine, “and is further evidence of Precision Spine’s continuing commitment to work with surgeons in the design and commercialization of advanced products that utilize the latest technology to help bring greater versatility, efficiency, and cost-effectiveness to the OR.”

The ShurFit ACIF 2C system is indicated for use in skeletally mature patients with degenerative disc disease (DDD) of the cervical spine at one disc level and consists of implants with various heights to accommodate individual patient anatomy and graft material size. It is implanted from the anterior approach at the C3 to C-7 disc levels and is designed to be packed with autogenous bone graft to help facilitate fusion while providing mechanical support to the implanted level until biologic fusion is achieved.

The ShurFit TLIF 2C and TPLIF 2C Interbody Fusion Devices are indicated for intervertebral body fusion of the spine in skeletally mature patients. The device system is designed for use with autograft to facilitate fusion. One device is used per intervertebral space for the TLIF 2C and TPLIF 2C system. Two devices are used per intervertebral space for the PLIF 2C system.

Hot this week

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.